Health
RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients – News-Medical.Net
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis…
RedHill Biopharma Ltd. (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Acting rapidly to ensure emergency transport and supply of drug, treatment was initiated with orally-administered opaganib within the past week. Opaganib is a novel, orally-administered sphingosine kinase-2 (SK2)…
-
Noosa News12 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business23 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News21 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
General13 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle